PetMed Express Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

PetMed ExpressDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -39.6% zurückgegangen, während in der Branche Specialty Retail die Gewinne wachsen. Die Umsätze sind rückläufig mit einer durchschnittlichen Rate von 1.6% pro Jahr.

Wichtige Informationen

-39.6%

Wachstumsrate der Gewinne

-39.5%

EPS-Wachstumsrate

Specialty Retail Wachstum der Industrie	26.6%
Wachstumsrate der Einnahmen	-1.6%
Eigenkapitalrendite	-7.7%
Netto-Marge	-2.7%
Letzte Ertragsaktualisierung	31 Mar 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers

Feb 22

PetMed Express: Avoid For Now

Jan 17

PetMed Express Needs A White Knight

Sep 26

Aufschlüsselung der Einnahmen und Ausgaben

Wie PetMed Express Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

NasdaqGS:PETS Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Mar 24	281	-7	79
31 Dec 23	277	-3	73
30 Sep 23	270	-1	70
30 Jun 23	265	1	64
31 Mar 23	257	5	60
31 Dec 22	259	9	54
30 Sep 22	261	13	51
30 Jun 22	263	17	49
31 Mar 22	272	19	50
31 Dec 21	279	22	49
30 Sep 21	284	25	47
30 Jun 21	292	27	49
31 Mar 21	304	24	51
31 Dec 20	312	31	51
30 Sep 20	306	30	51
30 Jun 20	300	28	50
31 Mar 20	284	26	48
31 Dec 19	274	25	48
30 Sep 19	275	26	48
30 Jun 19	276	31	48
31 Mar 19	283	38	47
31 Dec 18	286	41	45
30 Sep 18	286	43	45
30 Jun 18	282	41	45
31 Mar 18	274	37	44
31 Dec 17	270	35	43
30 Sep 17	262	30	42
30 Jun 17	256	27	41
31 Mar 17	249	24	40
31 Dec 16	242	22	39
30 Sep 16	240	22	40
30 Jun 16	236	21	41
31 Mar 16	235	21	43
31 Dec 15	229	20	43
30 Sep 15	228	20	44
30 Jun 15	228	18	44
31 Mar 15	229	17	46
31 Dec 14	228	17	47
30 Sep 14	229	17	48
30 Jun 14	232	18	48
31 Mar 14	233	18	49
31 Dec 13	236	18	49
30 Sep 13	235	18	49
30 Jun 13	233	18	50

Qualität der Erträge: PETS ist derzeit unrentabel.

Wachsende Gewinnspanne: PETS ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: PETS ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 39.6% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von PETS verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: PETS ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Specialty Retail (-12.3%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: PETS hat eine negative Eigenkapitalrendite (-7.72%), da es derzeit unrentabel ist.

PetMed Express Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2024 earnings: EPS misses analyst expectations

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Recent updates

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

Price target decreased to US$21.33

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

PetMed Express Puts Are Compelling

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.30 per share

Now 23% undervalued after recent price drop

PetMed Express CFO to leave post today, by remain with company over transition period

Consensus EPS estimates fall by 15%

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Petmed Express, Inc. Declares Quarterly Dividend, Payable on August 19, 2022

PetMed Express FQ1 2023 Earnings Preview

PetMed Express, Inc. Announces Executive Changes

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

PetMed Express, Inc. to Report Q1, 2023 Results on Jul 25, 2022

Price target decreased to US$23.33

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022